208 related articles for article (PubMed ID: 7748297)
21. The involvement of benzodiazepine receptor ligands in hepatic encephalopathy.
Basile AS; Jones EA
Hepatology; 1994 Aug; 20(2):541-3. PubMed ID: 8045517
[No Abstract] [Full Text] [Related]
22. Increased benzodiazepine-like activity is neither necessary nor sufficient to explain acute hepatic encephalopathy in the thioacetamide-treated rat.
Widler P; Fisch HU; Schoch P; Zimmermann A; Schläpfer TE; Reichen J
Hepatology; 1993 Dec; 18(6):1459-64. PubMed ID: 8080486
[TBL] [Abstract][Full Text] [Related]
23. Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Butterworth RF; Lavoie J; Giguère JF; Pomier-Layrargues G
Hepatology; 1988; 8(5):1084-8. PubMed ID: 2843451
[TBL] [Abstract][Full Text] [Related]
24. Increased density of brain histamine H(1) receptors in rats with portacaval anastomosis and in cirrhotic patients with chronic hepatic encephalopathy.
Lozeva V; Tuomisto L; Sola D; Plumed C; Hippeläinen M; Butterworth R
Hepatology; 2001 Jun; 33(6):1370-6. PubMed ID: 11391525
[TBL] [Abstract][Full Text] [Related]
25. Selective loss of binding sites for the glutamate receptor ligands [3H]kainate and (S)-[3H]5-fluorowillardiine in the brains of rats with acute liver failure.
Michalak A; Butterworth RF
Hepatology; 1997 Mar; 25(3):631-5. PubMed ID: 9049210
[TBL] [Abstract][Full Text] [Related]
26. Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.
Yurdaydin C; Gu ZQ; Nowak G; Fromm C; Holt AG; Basile AS
J Pharmacol Exp Ther; 1993 May; 265(2):565-71. PubMed ID: 8388453
[TBL] [Abstract][Full Text] [Related]
27. A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.
Zieve L; Ferenci P; Rzepczynski D; Ebner J; Zimmermann C
Metab Brain Dis; 1987 Sep; 2(3):201-5. PubMed ID: 2850457
[TBL] [Abstract][Full Text] [Related]
28. Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy.
Olasmaa M; Rothstein JD; Guidotti A; Weber RJ; Paul SM; Spector S; Zeneroli ML; Baraldi M; Costa E
J Neurochem; 1990 Dec; 55(6):2015-23. PubMed ID: 2172467
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy.
Rothstein JD; McKhann G; Guarneri P; Barbaccia ML; Guidotti A; Costa E
Ann Neurol; 1989 Jul; 26(1):57-62. PubMed ID: 2549847
[TBL] [Abstract][Full Text] [Related]
30. Changes in cerebral receptors for gamma aminobutyric acid in patients with hepatic encephalopathy.
Ferenci P; Riederer P; Jellinger K; Schafer DF; Jones EA
Liver; 1988 Aug; 8(4):225-30. PubMed ID: 2843723
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of the 18-kDa translocator protein: effects on the ammonia-induced mitochondrial permeability transition and cell swelling in cultured astrocytes.
Panickar KS; Jayakumar AR; Rama Rao KV; Norenberg MD
Glia; 2007 Dec; 55(16):1720-7. PubMed ID: 17893919
[TBL] [Abstract][Full Text] [Related]
32. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
Zeneroli ML
J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
[TBL] [Abstract][Full Text] [Related]
33. Benzodiazepine-receptor ligands and hepatic encephalopathy: a causal relationship?
Rothstein JD
Hepatology; 1994 Jan; 19(1):248-50. PubMed ID: 8276362
[No Abstract] [Full Text] [Related]
34. Plasma concentrations of endogenous benzodiazepine-receptor ligands in patients with hepatic encephalopathy: a comparative study.
Hernández-Avila CA; Shoemaker WJ; Ortega-Soto HA
J Psychiatry Neurosci; 1998 Sep; 23(4):217-22. PubMed ID: 9785700
[TBL] [Abstract][Full Text] [Related]
35. [Gamma-aminobutyric acid (GABA) metabolism in the rat brain in experimental hepatic encephalopathy].
Wysmyk-Cybula U
Neuropatol Pol; 1983; 21(4):519-27. PubMed ID: 6669231
[No Abstract] [Full Text] [Related]
36. Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth.
Alho H; Varga V; Krueger KE
Cell Growth Differ; 1994 Sep; 5(9):1005-14. PubMed ID: 7819126
[TBL] [Abstract][Full Text] [Related]
37. Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy.
Maddison JE; Dodd PR; Morrison M; Johnston GA; Farrell GC
Hepatology; 1987; 7(4):621-8. PubMed ID: 3038721
[TBL] [Abstract][Full Text] [Related]
38. [Gamma-aminobutyric acid (GABA) metabolism in the rat brain in experimental hepatic encephalopathy induced by carbon tetrachloride].
Wysmyk-Cybula U
Neuropatol Pol; 1984; 22(2):197-204. PubMed ID: 6483199
[No Abstract] [Full Text] [Related]
39. Current theories on the pathogenesis of hepatic encephalopathy.
Mousseau DD; Butterworth RF
Proc Soc Exp Biol Med; 1994 Sep; 206(4):329-44. PubMed ID: 7915420
[TBL] [Abstract][Full Text] [Related]
40. Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis.
Ahboucha S; Jiang W; Chatauret N; Mamer O; Baker GB; Butterworth RF
Neurogastroenterol Motil; 2008 Aug; 20(8):949-57. PubMed ID: 18482252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
